MedPath
HSA Approval

ESOZ TABLETS 40MG

SIN14633P

ESOZ TABLETS 40MG

ESOZ TABLETS 40MG

September 23, 2014

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRANBAXY (MALAYSIA) SDN. BHD.
Licence HolderRANBAXY (MALAYSIA) SDN. BHD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, ENTERIC COATED

ORAL

Medical Information

A02BC05

esomeprazole

Manufacturer Information

RANBAXY (MALAYSIA) SDN. BHD.

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Active Ingredients

Esomeprazole Magnesium (Amorphous) 41.40mg eqv to Esomeprazole

40.00mg

Esomeprazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ESOZ TABLETS 40MG - HSA Approval | MedPath